KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
64 hedge funds and large institutions have $88.7M invested in Kindred Biosciences, Inc. in 2014 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
60% less call options, than puts
Call options by funds: $4K | Put options by funds: $10K
Holders
64
Holding in Top 10
2
Calls
$4K
Puts
$10K
Top Buyers
| 1 | +$2.23M | |
| 2 | +$2.23M | |
| 3 | +$1M | |
| 4 |
LCM
Leonard Capital Management
Vero Beach,
Florida
|
+$857K |
| 5 |
JIC
Johnson Investment Counsel
Cincinnati,
Ohio
|
+$470K |
Top Sellers
| 1 | -$2.17M | |
| 2 | -$1.9M | |
| 3 | -$1.68M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.62M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.22M |